Drugs for Shoulder Impingement Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 72)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Triamcinolone |
Approved, Vet_approved |
Phase 4,Phase 2,Not Applicable |
|
124-94-7 |
31307
|
Synonyms:
(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
11.Beta.,16.alpha.,17.alpha., 21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11.beta.,16.alpha.,17.alpha.,21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11b,16a,17a,21-Tetrahydroxy-9a-fluoro-1,4-pregnadiene-3,20-dione
11beta,16alpha,17alpha,21-Tetrahydroxy-9alpha-fluoro-1,4-pregnadiene-3,20-dione
11-beta,16-alpha,17-alpha,21-Tetrahydroxy-9-alpha-fluoro-1,4-pregnadiene-3,20-dione
11β,16α,17α,21-tetrahydroxy-9α-fluoro-1,4-pregnadiene-3,20-dione
124-94-7
4-08-00-03629 (Beilstein Handbook Reference)
83474-03-7
9.Alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahy
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.Alpha.-Fluoro-11.beta.,16.alpha.,17.alpha., 21-tetrahydroxypregna-1,4-diene-3,20-d
9.alpha.-Fluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-16.alpha.-hydroxyprednisolone
9a-fluoro-11b,16a,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione
9a-fluoro-11b,16a,17a,21-Tetrahydroxypregna-1,4-diene-3,20-dione
9a-fluoro-16a-Hydroxyprednisolone
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9alpha-fluoro-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-fluoro-11beta,16alpha,17alpha,21-Tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-fluoro-16alpha-Hydroxyprednisolone
9alpha-Fluoro-16alpha-hydroxyprednisolone
9-alpha-Fluoro-16-alpha-hydroxyprednisolone
9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-fluoro-11b,16a,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione
9-fluoro-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione
9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-16α-hydroxyprednisolone
AC1L1LDH
AC1Q5HJC
AC-2072
Adcortyl
Aristocort
Aristocort A
Aristocort Tablets
Aristogel
Aristospan
Azmacort
Bio-0662
BPBio1_000154
BRD-K77554836-001-03-3
BRN 2341955
BSPBio_000140
C21H27FO6
Celeste
CHEMBL1451
CID31307
Cinolone
Cinolone-T
CL 19823
D00385
D014221
DB00620
Delphicort
droxypregna-1,4-diene-3,20-dione
EINECS 204-718-7
EU-0101179
Fluoxiprednisolone
Fluoxyprednisolone
Flutex
Fougera
HMS1568G22
HMS2090D12
HSDB 3194
ione
Kenacort
Kenacort (TN)
Kenacort-A
Kenacort-Ag
Kenacort-AG
Kenalog
Kenalog in Orabase
|
Kenalog-10
Kenalog-40
Kenalog-H
Ledercort
Lopac0_001179
LS-698
MLS000028542
MLS001066543
MLS002695935
MolPort-002-528-981
Mycolog
Nasacort
Nasacort Aq
Nasacort Hfa
NCGC00021580-03
NCGC00021580-04
NCGC00021580-05
NCGC00021580-06
NCGC00021580-07
nchembio.2007.53-comp7
NCI60_000750
NSC 13397
NSC13397
Omcilon
Omicilon
Oracort
Oralone
Orion
Polcortolon
Pregna-1,4-diene-3,20-dio
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha)
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy- (8CI)
Prestwick_438
Prestwick0_000120
Prestwick1_000120
Prestwick2_000120
Prestwick3_000120
Rodinolone
S1933_Selleck
Sk-Triamcinolone
SK-Triamcinolone
SMP1_000300
SMR000058333
SPBio_002079
T6376_SIGMA
Tiamcinolonum
Tiamcinolonum [INN-Latin]
Triacet
Triacort
Triamcet
Triamcinalone
Triamcinlon
Triamcinolon
Triamcinolona
Triamcinolona [INN-Spanish]
triamcinolone
Triamcinolone (JP15/USP/INN)
TRIAMCINOLONE (SEE ALSO TRIAMCINOLONE ACETONIDE (76-25-5) AND TRIAMCINOLONE DIACETATE (67-78-7))
Triamcinolone [USAN:INN:BAN:JAN]
Triamcinolone acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Triamcinolonum
Triamcinolonum [INN]
Triam-Tablinen
Triatex
Tricortale
Triderm
Trilone
Tri-Nasal
Tristoject
Trymex
UNII-1ZK20VI6TY
Vetalog
Volon
Volon A
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ GQ
ZINC03882036
|
|
2 |
|
Lidocaine |
Approved, Vet_approved |
Phase 4,Phase 2,Not Applicable |
|
137-58-6 |
3676
|
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(diethylamino)-2',6'-Acetoxylidide
2-(Diethylamino)-2',6'-acetoxylidide
2-(diethylamino)-N-(2,6-Dimethylphenyl)acetamide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-2ETN-2MePhAcN
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
a-diethylamino-2,6-Dimethylacetanilide
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
AKOS001026768
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
Alphacaine
alpha-diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-Dimethylacetanilide
alpha-Diethylamino-2,6-dimethylacetanilide
Anestacon
Anestacon Jelly
ARONIS23855
Astrazeneca brand OF lidocaine
BIDD:GT0342
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
C07073
C14H22N2O
Cappicaine
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
Cito optadren
CPD000058189
Cuivasil
D00358
Dalcaine
DB00281
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jenapharm brand OF lidocanine hydrochloride
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L0156
L1026_SIGMA
L7757_SIGMA
Lanabiotic
L-Caine
|
Leostesin
Lida-Mantle
Lidocaina
Lidocaina [INN-Spanish]
lidocaine
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine [USAN:INN:JAN]
Lidocaine carbonate
Lidocaine Carbonate
Lidocaine carbonate (2:1)
Lidocaine hydrocarbonate
Lidocaine Hydrocarbonate
Lidocaine hydrochloride
Lidocaine monoacetate
Lidocaine monohydrochloride
Lidocaine Monohydrochloride
Lidocaine monohydrochloride, monohydrate
Lidocaine sulfate (1:1)
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
LIDOPEN
Lignocaine
Lignocainum
Lingocaine
Lopac0_000669
Lopac-L-5647
LQZ
LS-805
Maricaine
Maybridge1_002571
MLS000069724
MLS000758263
MLS001074177
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
nchembio.65-comp16
NINDS_000174
Norwood Sunburn Spray
Novocol brand OF lidocaine hydrochloride
NSC 40030
NSC40030
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
Solarcaine aloe extra burn relief cream
Solcain
SPBio_001525
SPBio_002100
Spectrum_001118
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
STK552033
Strathmann brand OF lidocaine hydrochloride
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
α-diethylamino-2,6-dimethylacetanilide
|
|
3 |
|
Dexamethasone |
Approved, Investigational, Vet_approved |
Phase 4 |
|
50-02-2 |
5743
|
Synonyms:
(3H)-Dexamethasone
.delta.(sup 1)-9-.alpha.-Fluoro-16-.alpha.-methylcortisol
.gamma.corten
137098-19-2
16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol
16.alpha.-Methyl-9.alpha.-fluoroprednisolone
16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol
16alpha -Methyl-9alpha -fluoroprednisolone
16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol
16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol
16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone
16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone
16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone
16alpha-Methyl-9alpha-fluoroprednisolone
16-alpha-Methyl-9-alpha-fluoroprednisolone
16a-Methyl-9a-fluoro-1-dehydrocortisol
16α-methyl-9α-fluoro-1-dehydrocortisol
16α-Methyl-9α-fluoro-1-dehydrocortisol
1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone
1-dehydro-16alpha -Methyl-9alpha -fluorohydrocortisone
1-dehydro-16alpha-Methyl-9alpha-fluorohydrocortisone
1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone
1-dehydro-16a-Methyl-9a-fluorohydrocortisone
1-dehydro-16α-methyl-9α-fluorohydrocortisone
1-Dehydro-16α-methyl-9α-fluorohydrocortisone
23495-06-9
31375_FLUKA
46165_FLUKA
46165_RIEDEL
50-02-2
8054-59-9
9.alpha.-Fluoro-16.alpha.-methylprednisolone
906422-84-2
9a-fluoro-16a-Methylprednisolone
9a-fluoro-16BETA-METHYLPREDNISOLONE
9A-FLUORO-16BETA-METHYLPREDNISOLONE
9alpha -fluoro-16alpha -Methylprednisolone
9alpha-fluoro-16alpha-Methylprednisolone
9alpha-fluoro-16alpha-Methyl-prednisolone
9-alpha-fluoro-16-alpha-Methylprednisolone
9alpha-Fluoro-16alpha-methylprednisolone
9-alpha-Fluoro-16-alpha-methylprednisolone
9-fluoro-11,17,21-Trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-fluoro-11alpha -Methylpregna-1,4-diene-3,20-dione
9-fluoro-16-Methylprednisolone
9α-fluoro-16α-methylprednisolone
9α-Fluoro-16α-methylprednisolone
AC-11056
AC1L1L1H
AC1Q29DM
Adexone
Aeroseb-D
Aeroseb-dex
Aeroseb-Dex
AI3-50934
Ak dex OPH otic soln 0.1%
Alcon brand OF dexamethasone
Alcon Brand of Dexamethasone
alpha -fluoro-16-alpha -Methylcortisol
Anaflogistico
Aphtasolon
Aphthasolone
apo-Dexamethasone
Auxiron
Azimycin (veterinary)
Azium
Azium (veterinary)
Azium (Veterinary)
BIDD:ER0494
BIDD:PXR0060
Bisu Ds
Bisu DS
BRD-K38775274-001-02-3
BRD-K38775274-001-06-4
BSPBio_000995
C15643
C22H29FO5
Calonat
CCRIS 7067
CHEBI:41879
CHEMBL384467
CID5743
Corson
Corsone
Cortisumman
CPD001227192
CPD-10549
D00292
D003907
D1756_SIGMA
D4902_SIGMA
D6645_SIGMA
D8893_SIGMA
D9184_SIGMA
DB01234
Decacort
Decacortin
Decaderm
Decadron
Decadron (TN)
Decadron Tablets, Elixir
Decadron, Dexamethasone
Decadron-La
Decadron-LA
Decagel
Decaject
Decaject l.a.
Decaject L.A.
Decaject-l.a.
Decaject-L.A.
Decalix
Decameth
Decasone
Decaspray
Dectancyl
Dekacort
delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol
delta1-9alpha-Fluoro-16alpha-methylcortisol
Delta1-9alpha-fluoro-16alpha-Methylcortisol
Deltafluorene
Dergramin
Deronil
Desadrene
Desametasone
Desametasone [Dcit]
Desametasone [DCIT]
Desamethasone
Desameton
Deseronil
DEX
Dexa
DEXA
Dexa mamallet
Dexa Mamallet
Dexacen-4
Dexacidin
Dexacort
Dexacortal
Dexa-cortidelt
Dexa-Cortidelt
Dexacortin
Dexa-cortisyl
Dexa-Cortisyl
Dexadeltone
Dexafarma
Dexair
Dexalona
Dexaltin
Dexa-Mamallet
Dexametasona
Dexametasona [INN-Spanish]
Dexametasone
Dexameth
Dexamethansone
dexamethasone
Dexamethasone
Dexamethasone (JP15/USP/INN)
|
Dexamethasone [INN:BAN:JAN]
Dexamethasone acetate
Dexamethasone Acetate
Dexamethasone alcohol
Dexamethasone Alcohol
Dexamethasone base
Dexamethasone Base
Dexamethasone intensol
Dexamethasone Intensol
Dexamethasone sodium phosphate
Dexamethasone Sodium Phosphate
Dexamethasone-omega
Dexamethasonum
Dexamethasonum [INN-Latin]
Dexamethazone
Dexamonozon
Dexapolcort
Dexapos
Dexaprol
Dexa-scheroson
Dexa-Scheroson
Dexa-sine
Dexa-Sine
Dexason
Dexasone
Dexasone 0.5MG
Dexasone 0.75MG
Dexasone 4MG
Dexasporin
Dex-ide
Dex-Ide
Dexinolon
Dexinoral
Dexone
Dexone 0.5
DEXONE 0.5
Dexone 0.75
DEXONE 0.75
Dexone 1.5
DEXONE 1.5
Dexone 4
DEXONE 4
Dexonium
Dexpak
Dextelan
Dezone
Dinormon
DXM
Dxms
DXMS
ECR brand OF dexamethasone
ECR Brand of Dexamethasone
EINECS 200-003-9
Fluormethylprednisolone
Fluormone
Fluorocort
Fortecortin
Foy brand OF dexamethasone
Foy Brand of Dexamethasone
FT-0080377
Gammacorten
Hexadecadrol
Hexadrol
Hexadrol elixir
Hexadrol Elixir
Hexadrol Tablets
Hl-dex
Hl-Dex
HL-Dex
HMS1792A17
HMS1990A17
HMS2089N13
HSDB 3053
I06-1196
ICN brand OF dexamethasone
ICN Brand of Dexamethasone
IontoDex
isopto-Dex
Isopto-Dex
Lokalison F
Loverine
LS-7300
Luxazone
Maxidex
Maxidex ont 0.1%
Maxidex sus 0.1%
Maxitrol
Mediamethasone
Merck brand OF dexamethasone
Merck Brand of Dexamethasone
Merz brand 1 OF dexamethasone
Merz Brand 1 of Dexamethasone
Merz brand 2 OF dexamethasone
Merz Brand 2 of Dexamethasone
Methylfluorprednisolone
Mexidex
Millicorten
MK 125
MLS001055412
MLS001332507
MLS001332508
MolMap_000018
MolPort-003-846-433
Mymethasone
Naquasone (veterinary)
NCGC00091019-01
NCGC00091019-02
NCGC00091019-03
NCGC00091019-04
NCGC00091019-05
nchembio809-comp2
NCI60_003067
Neomycin and polymyxin b sulfates and dexamethasone
Neomycin and polymyxin b sulphates and dexamethasone
NSC 34521
NSC34521
Ocu-trol
Ocu-Trol
Oradexon
OTO-104
Pet derm III
Pet Derm Iii
Pet Derm III
Pet-Derm Iii
PHL-Dexamethasone
PMS Dexamethasone elixir 0.5mg/5ML
PMS-Dexamethasone
Policort
Posurdex
Prednisolon F
Prednisolone F
Prodex
S1322_Selleck
SAM002548948
Sandoz dexamethasone
SGCUT00126
Sk-Dexamethasone
SK-Dexamethasone
SMP1_000092
SMR000857119
SMR001227192
Spectrum5_002019
Spoloven
ST50307091
Sunia sol D
Sunia Sol D
Superprednol
TL8003317
to_000038
Tobradex
Tobramycin and dexamethasone
Tresaderm (veterinary)
Turbinaire
UNII-7S5I7G3JQL
Visumetazone
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ G1
ZINC03875332
|
|
4 |
|
Dexamethasone acetate |
Approved, Investigational, Vet_approved |
Phase 4 |
|
1177-87-3 |
|
Synonyms:
16alpha-Methyl-9alpha-fluoroprednisolone 21-acetate
9alpha-Fluoro-16alpha-methylprednisolone acetate
Dexamethasone 21-acetate
|
Dexamethasone acetate anhydrous
Dexamethasone acetate, anhydrous
Dexamethasoni acetas
|
|
5 |
|
Anti-Inflammatory Agents |
|
Phase 4,Phase 2,Not Applicable |
|
|
|
6 |
|
Peripheral Nervous System Agents |
|
Phase 4,Phase 2,Not Applicable |
|
|
|
7 |
|
glucocorticoids |
|
Phase 4,Phase 2,Not Applicable |
|
|
|
8 |
|
Hormone Antagonists |
|
Phase 4,Phase 2,Not Applicable |
|
|
|
9 |
|
Hormones |
|
Phase 4,Phase 2,Not Applicable |
|
|
|
10 |
|
Hormones, Hormone Substitutes, and Hormone Antagonists |
|
Phase 4,Phase 2,Not Applicable |
|
|
|
11 |
|
Anti-Arrhythmia Agents |
|
Phase 4,Phase 2,Not Applicable |
|
|
|
12 |
|
Triamcinolone hexacetonide |
|
Phase 4,Phase 2,Not Applicable |
|
|
|
13 |
|
Anesthetics, Local |
|
Phase 4,Phase 2,Not Applicable |
|
|
|
14 |
|
Immunosuppressive Agents |
|
Phase 4,Phase 2,Not Applicable |
|
|
|
15 |
|
Diuretics, Potassium Sparing |
|
Phase 4,Phase 2,Not Applicable |
|
|
|
16 |
|
Central Nervous System Depressants |
|
Phase 4,Phase 2,Not Applicable |
|
|
|
17 |
|
Immunologic Factors |
|
Phase 4,Phase 2,Phase 3,Not Applicable |
|
|
|
18 |
|
Anesthetics |
|
Phase 4,Phase 2,Not Applicable |
|
|
|
19 |
|
Sodium Channel Blockers |
|
Phase 4,Phase 2,Not Applicable |
|
|
|
20 |
|
triamcinolone acetonide |
|
Phase 4,Phase 2,Not Applicable |
|
|
|
21 |
|
Triamcinolone diacetate |
|
Phase 4,Phase 2,Not Applicable |
|
|
|
22 |
|
Antiemetics |
|
Phase 4,Not Applicable |
|
|
|
23 |
|
HIV Protease Inhibitors |
|
Phase 4 |
|
|
|
24 |
|
Gastrointestinal Agents |
|
Phase 4,Not Applicable |
|
|
|
25 |
|
protease inhibitors |
|
Phase 4 |
|
|
|
Synonyms:
|
26 |
|
Antineoplastic Agents, Hormonal |
|
Phase 4,Not Applicable |
|
|
|
27 |
|
Autonomic Agents |
|
Phase 4,Not Applicable |
|
|
|
28 |
|
BB 1101 |
|
Phase 4 |
|
|
|
29 |
|
Hyaluronic acid |
Approved, Vet_approved |
Phase 2, Phase 3,Not Applicable |
|
9004-61-9 |
53477741
|
Synonyms:
|
30 |
|
Adjuvants, Immunologic |
|
Phase 2, Phase 3,Not Applicable |
|
|
|
31 |
|
Viscosupplements |
|
Phase 2, Phase 3,Not Applicable |
|
|
|
32 |
|
Pharmaceutical Solutions |
|
Phase 2, Phase 3,Not Applicable |
|
|
|
33 |
|
Protective Agents |
|
Phase 2, Phase 3,Not Applicable |
|
|
|
34 |
|
Mitogens |
|
Phase 3 |
|
|
|
35 |
|
Benzyl alcohol |
Approved |
Phase 2 |
|
100-51-6 |
244
|
Synonyms:
(Hydroxymethyl)benzene
.alpha.-hydroxytoluene
.alpha.-toluenol
a-Hydroxytoluene
Alcohol, benzyl
Alcoholum benzylicum
Alcool benzylique
Alcoolbenzylique
alpha-Hydroxytoluene
alpha-Toluenol
Aromatic alcohol
Aromatic primary alcohol
a-Toluenol
Bentalol
Benzal alcohol
Benzalalcohol
Benzalcohol
Benzenecarbinol
Benzenemethanol
Benzenmethanol
Benzoyl alcohol
Benzyl alcohol
Benzyl alkohol
|
Benzyl-alcohol
BenzylAlcohol
Benzylalkohol
Benzylic alcohol
Benzylicum
Caswell no. 081F
Enzylalcohol
Euxyl K 100
Hydroxymethylbenzene
Hydroxytoluene
Itch-X
MBN
Methanol benzene
Phenolcarbinol
Phenylcarbinol
Phenylcarbinolum
Phenylmethanol
Phenylmethyl alcohol
Sunmorl BK 20
TB 13g
α-hydroxytoluene
α-toluenol
|
|
36 |
|
Tetracaine |
Approved, Vet_approved |
Phase 2 |
|
94-24-6 |
5411
|
Synonyms:
136-47-0 (mono-hydrochloride)
2-(dimethylamino)ethyl 4-(butylamino)benzoate
2-(Dimethylamino)ethyl 4-(butylamino)benzoate
2-(Dimethylamino)ethyl p-(butylamino)benzoate
2-dimethylaminoethyl 4-(butylamino)benzoate
2-Dimethylaminoethylester kyseliny p-butylaminobenzoove
2-Dimethylaminoethylester kyseliny p-butylaminobenzoove [Czech]
4-(Butylamino)benzoic acid 2-(dimethylamino)ethyl ester
4-[Butylamino]benzoic acid-2-[dimethylamino]ethyl ester
4-14-00-01172 (Beilstein Handbook Reference)
94-24-6
AB00053549
AC1L1KAQ
AC-3480
Amethocaine
Amethocaine (TN)
Amethocaine HCl
Anetain
Benzoic acid, 4-(butylamino)-, 2-(dimethylamino)ethyl ester
BENZOIC ACID, p-(BUTYLAMINO)-, 2-(DIMETHYLAMINO)ETHYL ESTER
BENZOIC ACID,4-BUTYLAMINO,2-DIMETHYLAMINOETHYL ESTER PANTOCAIN BASE
BPBio1_000422
BRD-K45071273-003-05-8
BRN 2216051
BSPBio_000382
BSPBio_001944
C07526
C15H24N2O2
CAS-136-47-0
CHEBI:9468
CHEMBL698
CID5411
Contralgin
D00551
Diaethylaminoaethanol ester der p-butylaminobenzoesaeure
Diaethylaminoaethanol ester der p-butylaminobenzoesaeure [German]
Diäthylaminoäthanol ester der p-butylaminobenzösäure
Dicain
Dicaine
Dikain
Dimethylaminoethyl p-butyl-aminobenzoate
DivK1c_000607
EINECS 202-316-6
Fissucain
I01-1872
IDI1_000607
InChI=1/C15H24N2O2/c1-4-5-10-16-14-8-6-13(7-9-14)15(18)19-12-11-17(2)3/h6-9,16H,4-5,10-12H2,1-3H
Intercain
KBio1_000607
KBio2_001512
KBio2_004080
KBio2_006648
KBio3_001444
|
KBioGR_000781
KBioSS_001512
Laudocaine
Lopac0_001211
Lopac-T-7508
LS-36312
Medicaine
Medihaler-Tetracaine
Meethobalm
Metraspray
MolPort-001-783-476
Mucaesthin
NCGC00016049-01
NCGC00016049-02
NCGC00016049-04
NCGC00162367-01
NINDS_000607
Niphanoid
p-(butylamino)benzoic acid β-(dimethylamino)ethyl ester
p-(Butylamino)benzoic acid, 2-(dimethylamino)ethyl ester
p-Butylaminobenzoyl-2-dimethylaminoethanol
Pontocaine
Prestwick0_000571
Prestwick1_000571
Prestwick2_000571
Prestwick3_000571
Rexocaine
SBB058194
SPBio_001455
SPBio_002601
Spectrum_001032
Spectrum2_001328
Spectrum3_000562
Spectrum4_000351
Spectrum5_001072
T3812_SIAL
T7383_SIAL
T7383_SIGMA
Tetracaina
Tetracaína
Tetracaina [INN-Spanish]
tetracaine
Tétracaïne
Tetracaine (USP/INN)
Tetracaine [USAN:INN]
Tetracaine HCl
Tetracainum
Tetracainum [INN-Latin]
Tetrakain
Tetrakain [Czech]
UNII-0619F35CGV
Uromucaesthin
|
|
37 |
|
Ethanol |
Approved |
Phase 2 |
|
64-17-5 |
702
|
Synonyms:
(C6-C9)Alkyl alcohol
[CH2Me(OH)]
[OEtH]
02483_FLUKA
02851_FLUKA
02853_FLUKA
02854_FLUKA
02855_FLUKA
02856_FLUKA
02856_SIAL
02857_FLUKA
02857_SIAL
02858_FLUKA
02858_SIAL
02860_FLUKA
02865_FLUKA
02865_SIAL
02870_FLUKA
02870_SIAL
02875_FLUKA
02877_FLUKA
02878_FLUKA
02882_FLUKA
02882_SIAL
02883_FLUKA
02884_FLUKA
02890_FLUKA
02890_SIAL
02891_FLUKA
02891_SIAL
100C.NPA
121182-78-3
187380_ALDRICH
187380_SIAL
1-Hydroxyethane
24102_RIEDEL
24102_SIAL
24103_RIEDEL
24103_SIAL
24105_RIEDEL
24105_SIAL
24106_RIEDEL
24106_SIAL
24194_RIEDEL
24194_SIAL
245119_ALDRICH
245119_SIAL
270741_ALDRICH
270741_SIAL
277649_ALDRICH
277649_SIAL
2858_SIGMA
29221_FLUKA
32205_RIEDEL
32205_SIAL
32221_RIEDEL
32221_SIAL
32294_RIEDEL
32294_SIAL
34870_SIAL
34963_RIEDEL
39278_FLUKA
40210_ALDRICH
40210_RIEDEL
41322_FLUKA
458600_ALDRICH
458600_SIAL
459828_ALDRICH
459828_SIAL
459836_ALDRICH
459836_SIAL
459844_SIAL
48075_SUPELCO
493511_SIAL
493538_ALDRICH
493538_SIAL
493546_ALDRICH
493546_SIAL
64-17-5
676829_SIAL
68475-56-9
71076-86-3
71329-38-9
8000-16-6
8024-45-1
absolute alcohol
Absolute alcohol
Absolute Alcohol
Absolute ethanol
Absolute Ethanol
Absolute ethyl alcohol
AC1L19TW
AC1Q31MM
Aethanol
Aethanol [German]
Aethylalkohol
AHD 2000
AI3-01706
Alcare hand degermer
Alcare Hand Degermer
alcohol
Alcohol
Alcohol (ethyl)
Alcohol (USP)
Alcohol [USP]
ALCOHOL 5% IN D5-W
Alcohol anhydrous
Alcohol Anhydrous
Alcohol dehydrated
Alcohol denatured
alcohol etilico
Alcohol etilico
Alcohol etílico
Alcohol, absolute
Alcohol, Absolute
Alcohol, anhydrous
Alcohol, dehydrated
Alcohol, Dehydrated
Alcohol, denatured
Alcohol, diluted
Alcohol, Diluted
Alcohol, ethyl
Alcohol, grain
Alcohol, Grain
Alcohols
Alcohols, C1-3
Alcohols, C30
Alcohols, C6-9
Alcool ethylique
Alcool Ethylique
Alcool éthylique
Alcool etilico
Alcool Etilico
Algrain
Alkohol
Alkohol [German]
Alkoholu etylowego
Alkoholu Etylowego
Aminoethanol
Anhydrol
Anhydrol PM 4085
Anhydrous alcohol
Anhydrous ethanol
Äthanol
Äthylalkohol
Beta-Aminoethanol
Beta-Aminoethyl Alcohol
Beta-Ethanolamine
Beta-Hydroxyethylamine
bmse000297
C00469
C2H5OH
C2H6O
Caswell No. 426
Caswell No. 430
CCRIS 945
CDA 19
CDA 19-200
CHEBI:16236
|
CHEMBL545
CID702
Colamine
Cologne spirit
Cologne Spirit
Cologne spirits
D000431
D00068
DB00898
Dehydrated alcohol
Dehydrated ethanol
Dehydrated Ethanol
Denatured alcohol
Denatured Alcohol
Denatured Alcohol Cd-10
Denatured Alcohol Cd-5
Denatured Alcohol Cd-5a
Denatured Alcohol Sd-1
Denatured Alcohol Sd-13a
Denatured Alcohol Sd-17
Denatured Alcohol Sd-23a
Denatured Alcohol Sd-28
Denatured Alcohol Sd-30
Denatured Alcohol Sd-39b
Denatured Alcohol Sd-39c
Denatured Alcohol Sd-3a
Denatured Alcohol Sd-40m
Denatured ethanol
Denatured Ethanol
Desinfektol el
Desinfektol EL
Diluted alcohol
Distilled spirits
E2385_SIGMA
E7023_ALDRICH
E7023_SIAL
E7148_ALDRICH
E7148_SIAL
E7517_SIGMA
EINECS 200-578-6
EINECS 270-649-4
Envision Conditioner Pdd 9020
EOH
EOX
Esumiru WK 88
ETA
etanol
Etanol
Etanolo
Etanolo [Italian]
ethanol
éthanol
Ethanol (9CI)
Ethanol [JAN]
Ethanol 200 proof
Ethanol 200 Proof
Ethanol Absolute
Ethanol Absolute Bp
Ethanol Anhydrous
Ethanol Extra Pure
Ethanol solution
Ethanol Vapor
Ethanol, Silent Spirit
Ethanol, undenatured
Ethanolum anhydricum
Ethicap
Ethyl alc
ethyl alcohol
Ethyl alcohol
Ethyl Alcohol
Ethyl Alcohol & Water, 10%
Ethyl Alcohol & Water, 20%
Ethyl Alcohol & Water, 30%
Ethyl Alcohol & Water, 40%
Ethyl Alcohol & Water, 5%
Ethyl Alcohol & Water, 50%
Ethyl Alcohol & Water, 60%
Ethyl Alcohol & Water, 70%
Ethyl Alcohol & Water, 80%
Ethyl Alcohol & Water, 95%
Ethyl Alcohol & Water, 96%
Ethyl alcohol anhydrous
Ethyl Alcohol Anhydrous
Ethyl alcohol in alcoholic beverages
Ethyl alcohol usp
Ethyl Alcohol, Anhydrous
Ethyl Alcohol, Denatured
Ethyl hydrate
Ethyl Hydrate
Ethyl hydroxide
Ethyl Hydroxide
Ethylalcohol
Ethylalcohol [Dutch]
Ethylol
Ethylolamine
Ethyloxy Group
EtOH
Etylowy alkohol
FEMA No. 2419
FEMA Number 2419
Fermentation alcohol
Glycinol
grain alcohol
Grain alcohol
Hinetoless
HSDB 531
HSDB 82
Hydroxyethane
HYDROXYETHYL GROUP
I14-12648
IMS 99
Infinity pure
Infinity Pure
Jaysol
Jaysol S
LS-1539
LTBB002977
Lux
Methylated spirit
Methylated Spirit Mineralised
Methylcarbinol
Molasses alcohol
MolPort-001-785-844
NCGC00091458-01
nchem.651-comp3c
nchembio.552-comp10
nchembio.94-comp20
NCI-C03134
NSC 85228
NSC85228
Oxydimethylene Group
potato Alcohol
Potato alcohol
Punctilious ethyl alcohol
Pyro
QMHAIh@
Reagent Alcohol
Ru-Tuss Expectorant
SDA 3A
SDA 40-2
SDM No. 37
Sekundasprit
Silent spirit
Spirit
Spirits of wine
Spirits OF wine
spiritus vini
Spiritus vini
Spirt
SY Fresh M
Synasol
Tecsol
Tecsol C
Thanol
Thiofaco M-50
Undenatured ethanol
UNII-3K9958V90M
USAF EK-1597
WLN: Q2
|
|
38 |
|
Acetylcholine |
Approved |
Phase 2 |
|
51-84-3 |
187
|
Synonyms:
2-(Acetyloxy)-N,N,N-trimethylethanaminium
Acetilcolina cusi
Acetyl choline ion
Acetylcholine bromide
Acetylcholine cation
acetylcholine chloride
Acetylcholine chloride
Acetylcholine Chloride
Acetylcholine fluoride
Acetylcholine hydroxide
Acetylcholine iodide
Acetylcholine L tartrate
Acetylcholine L-tartrate
Acetylcholine perchlorate
Acetylcholine picrate
Acetylcholine picrate (1:1)
Acetylcholine sulfate (1:1)
Acetylcholinium: acetyl-choline
ACh
|
Alcon brand OF acetylcholine chloride
Azetylcholin
Bournonville brand OF acetylcholine chloride
Bromide, acetylcholine
Bromoacetylcholine
Chloroacetylcholine
Choline acetate
Choline acetate (ester)
Choline acetic acid
Ciba vision brand OF acetylcholine chloride
Cusi, acetilcolina
Fluoride, acetylcholine
Hydroxide, acetylcholine
Iodide, acetylcholine
Iolab brand OF acetylcholine chloride
L-Tartrate, acetylcholine
Miochol
O-Acetylcholine
Perchlorate, acetylcholine
|
|
39 |
|
Carboxymethylcellulose Sodium |
|
Phase 2 |
|
|
|
40 |
|
Acetylcholine Release Inhibitors |
|
Phase 2 |
|
|
|
41 |
|
onabotulinumtoxinA |
|
Phase 2 |
|
|
|
42 |
|
Cholinergic Agents |
|
Phase 2 |
|
|
|
43 |
|
Neurotransmitter Agents |
|
Phase 2 |
|
|
|
44 |
|
Botulinum Toxins |
|
Phase 2 |
|
|
|
45 |
|
abobotulinumtoxinA |
|
Phase 2 |
|
|
|
46 |
|
Botulinum Toxins, Type A |
|
Phase 2 |
|
|
|
47 |
|
sodium thiosulfate |
|
Phase 2 |
|
|
|
48 |
|
Anti-Bacterial Agents |
|
Phase 2 |
|
|
|
49 |
|
Antioxidants |
|
Phase 2 |
|
|
|
50 |
|
Anti-Infective Agents |
|
Phase 2 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 114)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Radio-frequency (RF)-Based Plasma Micro-tenotomy for the Treatment of Shoulder Impingement Syndrome |
Completed |
NCT01554670
|
Phase 4 |
|
2 |
Low Level Laser Therapy Associated With Exercise in Subacromial Impingement Syndrome |
Completed |
NCT02725749
|
Phase 4 |
|
3 |
Dexamethasone for Pain After Shoulder Surgery |
Completed |
NCT01414569
|
Phase 4 |
Dexamethasone |
4 |
Combined Corticosteroid With Low Volume Compared to High Volume in Impingement Syndrome |
Completed |
NCT03120923
|
Phase 4 |
Lidocaine 3 cc;Lidocaine 9 cc;Triamcinolone Acetonide |
5 |
Subacromial Decompression Versus Subacromial Bursectomy for Patients With Rotator Cuff Tendinosis |
Unknown status |
NCT00196573
|
Phase 3 |
|
6 |
Supervised Exercises Compared With Radial Extracorporal Shock Wave Therapy (rESWT) in Patients With SIS |
Unknown status |
NCT00653081
|
Phase 3 |
|
7 |
Radial Extracorporeal Shock Wave Therapy (rESWT) Treatment of Subacromial Shoulder Pain |
Unknown status |
NCT01441830
|
Phase 3 |
|
8 |
Ultrasonography Guided Subacromial Sodium Hyaluronate Injection in Rotator Cuff Disease |
Unknown status |
NCT01735058
|
Phase 2, Phase 3 |
Sodium Hyaluronate;Normal saline |
9 |
The Influence of Growth Factors (PDGF), Applied as Autologous Thrombocyte Concentrate, on Functional Recovery |
Completed |
NCT01510639
|
Phase 3 |
|
10 |
Glenohumeral Re-centering During Closed Kinetic Chain for Shoulder Physiotherapy. A Prospective and Randomized Study. |
Recruiting |
NCT02874105
|
Phase 3 |
|
11 |
Pain Patch Versus Injections in the Treatment of Pain Associated With Shoulder Impingement Syndrome |
Unknown status |
NCT01544283
|
Phase 2 |
Synera® (lidocaine 70 mg and tetracaine 70 mg) topical patch;Triamcinolone Acetonide |
12 |
Study of the Treatment of Tendinopathy Unruptured of Rotator Cuff by Intramuscular Injection of Botulinum Toxin |
Unknown status |
NCT02867787
|
Phase 2 |
Botox arm |
13 |
Study Evaluating Heated Lidocaine/Tetracaine Topical Patch in Treatment of Patients With Shoulder Impingement Syndrome |
Completed |
NCT01055444
|
Phase 2 |
Heated lidocaine and tetracaine topical patch |
14 |
Exercise and Manual Therapy for Shoulder Subacromial Impingement Syndrome |
Completed |
NCT00632996
|
Phase 2 |
|
15 |
Neck Mobs and Impingement |
Completed |
NCT01744002
|
Phase 2 |
|
16 |
Efficacy and Tolerance of Sodium Thiosulfate Injection After Ultrasound-guided Percutaneous Irrigation of Calcific Tendinopathy of the Rotator Cuff |
Completed |
NCT02538939
|
Phase 2 |
Sodium thiosulfate |
17 |
Prediction Frozen Shoulder Validation |
Completed |
NCT01157221
|
Phase 1, Phase 2 |
|
18 |
Exercise Application in the Treatment of Patients With Shoulder Impingement |
Not yet recruiting |
NCT02695524
|
Phase 2 |
|
19 |
The Clinical Efficacy of Belting Stabilization for Shoulder Pain |
Completed |
NCT00826293
|
Phase 1 |
|
20 |
Study of the Effect of Neck Treatment on Shoulder Impingement |
Terminated |
NCT00764764
|
Phase 1 |
|
21 |
Conservative or Operative Treatment for the Shoulder Impingement Syndrome? |
Unknown status |
NCT00349648
|
Not Applicable |
|
22 |
Efficacy of Electrotherapy in Subacromial Impingement Syndrome |
Unknown status |
NCT01073956
|
Not Applicable |
|
23 |
Teres Major Muscle and Subacromial Impingement Syndrome |
Unknown status |
NCT02374125
|
Not Applicable |
|
24 |
Exercise in the Physiotherapy Management of Shoulder Impingement |
Unknown status |
NCT01691157
|
Not Applicable |
|
25 |
Effectiveness of Telerehabilitation Program in Subacromial Syndrome (Telerehab Sis) |
Unknown status |
NCT02909920
|
Not Applicable |
|
26 |
Effect of Exercise Programs on 3-dimensional Scapular Kinematics, Disability and Pain |
Unknown status |
NCT02286310
|
Not Applicable |
|
27 |
Evaluation of the Difference in the Acromion Humerus Gap at Sitting,Lying |
Unknown status |
NCT01264926
|
|
|
28 |
ArthroPlanner: A Surgical Planning Solution for Acromioplasty |
Unknown status |
NCT02725346
|
Not Applicable |
|
29 |
Shoulder Brace on Muscle Activation and Scapular Kinematics in Patients With Shoulder Impingement Syndrome and Rounded Shoulder Posture |
Completed |
NCT03667833
|
Not Applicable |
|
30 |
Effects of Eccentric Training for Shoulder Abductors in Subjects With Shoulder Impingement Syndrome |
Completed |
NCT01090271
|
Not Applicable |
|
31 |
Effects of Mulligan's Technique in Subjects With Shoulder Impingement Syndrome |
Completed |
NCT02463526
|
Not Applicable |
|
32 |
Physical Therapy Versus Steroid Injection for Shoulder Impingement Syndrome |
Completed |
NCT01190891
|
Not Applicable |
|
33 |
Study of Neurocognitive Therapeutic Exercise in the Shoulder Impingement Syndrome in Comparison With Traditional Therapeutic Exercise |
Completed |
NCT01785745
|
Not Applicable |
|
34 |
Standardized and Modified Corticosteroid Subacromial Injection for Shoulder Impingement Syndrome |
Completed |
NCT03148353
|
Not Applicable |
|
35 |
Randomized Clinical Trial of Rehabilitation for Subacromial Impingement Syndrome |
Completed |
NCT00633451
|
Not Applicable |
|
36 |
Subacromial Impingement Syndrome Approach Using High Intensity Laser Therapy |
Completed |
NCT02971215
|
Not Applicable |
|
37 |
Progressive Resistance Training of the Biceps in Subacromial Impingement Syndrome |
Completed |
NCT01314196
|
Not Applicable |
|
38 |
A New Shoulder Proprioceptive Rehabilitative Tool (SRPT) for the Evaluation of the Role of the Shoulder During Reaching |
Completed |
NCT02646306
|
|
|
39 |
Effects of Cryotherapy on Joint Function and Pressure Pain Threshold in Patients With Subacromial Impingement Syndrome. |
Completed |
NCT02351986
|
Not Applicable |
|
40 |
Effects of Overload Progressive in the Treatment of Shoulder |
Completed |
NCT02870257
|
Not Applicable |
|
41 |
Subacromial Injection of Allogeneic Platelet Rich Plasma (PRP) for Shoulder Impingement Syndrome |
Completed |
NCT02019537
|
Not Applicable |
|
42 |
Mobilization With Movement for Shoulder Impingement |
Completed |
NCT02172079
|
Not Applicable |
|
43 |
Comparison of the Proprioceptive Neuromuscular Facilitation and Mobilization In Subacromial Impingement Syndrome |
Completed |
NCT03735485
|
Not Applicable |
|
44 |
Exercise Training Sequence for Subacromial Impingement Syndrome |
Completed |
NCT02478567
|
Not Applicable |
|
45 |
Supervised Exercise Therapy vs Home Exercises for Patients With Subacromial Impingement |
Completed |
NCT01257113
|
Not Applicable |
|
46 |
Effectiveness of Two Electrotherapy Techniques to Treat Subacromial Impingement Syndrome |
Completed |
NCT02110030
|
Not Applicable |
|
47 |
Comparison of Exercise Interventions in Adults With Subacromial Impingement Syndrome |
Completed |
NCT01508715
|
Not Applicable |
|
48 |
Acupuncture Treatment of Shoulder Impingement Syndrome |
Completed |
NCT02449668
|
Not Applicable |
|
49 |
Subacute Effects of Spinal Mobilization to Treat Subacromial Impingement |
Completed |
NCT01753271
|
Not Applicable |
|
50 |
Assessment of Thoracolumbar Fascia Length |
Completed |
NCT03415438
|
|
|
|